Qualitative and quantitative research of medication review and drug-related problems in Hungarian community pharmacies: A pilot study

András Szilvay, Orsolya Somogyi, Attiláné Meskó, Romána Zelkó, Balázs Hankó

Research output: Contribution to journalArticle

3 Citations (Scopus)


Background: Pharmaceutical care is the pharmacist's contribution to the care of individuals to optimize medicines use and improve health outcomes. The primary tool of pharmaceutical care is medication review. Defining and classifying Drug-Related Problems (DRPs) is an essential pillar of the medication review. Our objectives were to perform a pilot of medication review in Hungarian community pharmacies, a DRP classification was applied for the first time. Also, our goal was the qualitative and quantitative description of the discovered DRPs, and of the interventions for their solution in order to prove the safety relevance of the service and to map out the competence limits of GPs and community pharmacists to drug therapy. Methods: The project took place in Hungarian community pharmacies. The study was performed with patients taking vitamin K antagonist (VKA) and/or ACE inhibitor and NSAID simultaneously (ACEI-NSAID). 61 pharmacists and 606 patients participated in the project. Pharmacists reviewed the medication for 3 months and the classification of DRPs was performed (category of DRP1 - DRP6). Patient data were statistically analyzed. Results: Patients consumed on average 7.9 ± 3.1 medications and other products. 571 DRPs were detected in 540 patients, averaging 1.06 DRPs per patient (SD = 1.07). The highest frequency category was DRP5 (non-quantitative safety problem; 51.0%). The most common root cause was an interaction (42.0%) and non-adherence (19.4%.). The most commonly used intervention was education (25.4%) and medication replacement by the pharmacist (20.1%). The changing of the frequency and dosage in any direction were negligible. Conclusions: Patients are struggling with many DRPs that can be assessed and categorized by this system and which remain unrecognizable without pharmacists. Further projects need to be developed to assist in the development of physician-pharmacist cooperation and the widespread dissemination of pharmaceutical care.

Original languageEnglish
Article number282
JournalBMC Health Services Research
Issue number1
Publication statusPublished - May 3 2019


  • ACE inhibitor
  • Community pharmacy
  • Drug-related problem
  • Medication review
  • Pharmaceutical care
  • Vitamin K antagonist

ASJC Scopus subject areas

  • Health Policy

Fingerprint Dive into the research topics of 'Qualitative and quantitative research of medication review and drug-related problems in Hungarian community pharmacies: A pilot study'. Together they form a unique fingerprint.

  • Cite this